20378355|t|Is there an association of regulatory region polymorphism in the alpha-1-antichymotrypsin gene with sporadic Alzheimer's disease in the northern Han-Chinese population?
20378355|a|Both invitro and invivo alpha-1-antichymotrypsin (ACT) directly inhibits amyloid beta peptide (Abeta) degradation and promotes Abeta deposition. However, whether the genetic variants in the regulatory region (including the promoter and the two enhancers) of the ACT gene affect susceptibility to Alzheimer's disease (AD) remains controversial. Here, we screened ACT promoter and enhancers in 244 patients with sporadic Alzheimer's disease (SAD) and 205 control patients, both of north Han-Chinese origin. Four single nucleotide polymorphisms (SNP) were found: (i) 11510T/C (rs10145747, named as ACT1); 11496G/A (rs4375593, ACT2); (iii) 11491T/C (rs4508366, ACT3); and (iv) 51G/T (rs1884082, ACT4). Neither individual SNP nor haplotypes were associated with AD onset. We concluded that the effect of the variations in the ACT regulatory region must be very limited, if occurring at all.
20378355	65	89	alpha-1-antichymotrypsin	Gene	12
20378355	109	128	Alzheimer's disease	Disease	MESH:D000544
20378355	193	217	alpha-1-antichymotrypsin	Gene	12
20378355	264	269	Abeta	Gene	351
20378355	296	301	Abeta	Gene	351
20378355	465	484	Alzheimer's disease	Disease	MESH:D000544
20378355	486	488	AD	Disease	MESH:D000544
20378355	565	573	patients	Species	9606
20378355	588	607	Alzheimer's disease	Disease	MESH:D000544
20378355	609	612	SAD	Disease	MESH:D000544
20378355	630	638	patients	Species	9606
20378355	733	741	11510T/C	DNAMutation	tmVar:g|SUB|T|11510|C;HGVS:g.11510T>C;VariantGroup:1;CorrespondingGene:101929055;RS#:10145747;CA#:265930830
20378355	743	753	rs10145747	SNP	tmVar:rs10145747;VariantGroup:1;CorrespondingGene:101929055;RS#:10145747
20378355	764	768	ACT1	Gene	10758
20378355	771	779	11496G/A	DNAMutation	tmVar:g|SUB|G|11496|A;HGVS:g.11496G>A;VariantGroup:3;CorrespondingGene:101929055;RS#:4375593;CA#:14058377
20378355	781	790	rs4375593	SNP	tmVar:rs4375593;VariantGroup:3;CorrespondingGene:101929055;RS#:4375593
20378355	792	796	ACT2	Gene	6351
20378355	805	813	11491T/C	DNAMutation	tmVar:g|SUB|T|11491|C;HGVS:g.11491T>C;VariantGroup:2;CorrespondingGene:101929055;RS#:4508366
20378355	815	824	rs4508366	SNP	tmVar:rs4508366;VariantGroup:2;CorrespondingGene:101929055;RS#:4508366
20378355	842	847	51G/T	DNAMutation	tmVar:c|SUB|G|51|T;HGVS:c.51G>T;VariantGroup:0;CorrespondingGene:12;RS#:1884082;CorrespondingSpecies:9606;CA#:7329594
20378355	849	858	rs1884082	SNP	tmVar:rs1884082;VariantGroup:0;CorrespondingGene:12;RS#:1884082;CorrespondingSpecies:9606
20378355	926	928	AD	Disease	MESH:D000544
20378355	Association	MESH:D000544	12
20378355	Negative_Correlation	12	351

